Skip to content
Terms & Conditions
Merck to Acquire ArQule for $2.7B
AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III ELEVATE TN Study for Previously Untreated Chronic Lymphocytic Leukemia
Amgen’s Avsola (biosimilar, infliximab) Receives the US FDA’s Approval for the Same Indications as Remicade (infliximab)
Boehringer Ingelheim Collaborates with Healx to Identify New Treatments for Rare Neurological Diseases
Sobi’s Dova Pharmaceutical Reports Results of an Online Survey Highlighting Disease Burden and Impact for Patients with Immune Thrombocytopenia
Insights+ Key Biosimilars Events of November 2019
Top Biosimilar Companies with Approved and Pipeline Products in the US and EU
Subscribe To Our News Alerts
Join our mailing list to receive the latest news alerts from PharmaShots.
You are now subscribed to our NewsAlerts!